Clinical Trial Update: Safety, Feasibility and Efficacy of Sulforaphane (Avmacol Extra Strength) in Chronic Kidney Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating safety, feasibility and efficacy of sulforaphane (Avmacol Extra Strength) in chronic kidney disease. The study is currently ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Avmacol Extra Strength (sulforaphane)

Snippet

Sponsor: University of Rochester | Conditions: Chronic Kidney Disease Stage 3, Chronic Kidney Disease Stage 4 | Phase 2 | Status: ACTIVE_NOT_RECRUITING